Cargando…

Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis

The prognosis of oral cancer that has metastasized to the contralateral cervical lymph nodes is poor, although the appropriate treatment method has not been established because of its rarity. A multicenter retrospective study on the treatment and prognosis of pN2c oral cancer patients was conducted....

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Yuki, Otsuru, Mitsunobu, Hasegawa, Takumi, Akashi, Masaya, Yamada, Shin-ichi, Kurita, Hiroshi, Okura, Masaya, Yamakawa, Nobuhiro, Kirita, Tadaaki, Yanamoto, Souichi, Umeda, Masahiro, Kojima, Yuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368347/
https://www.ncbi.nlm.nih.gov/pubmed/35954583
http://dx.doi.org/10.3390/ijerph19159229
_version_ 1784766099193069568
author Sakamoto, Yuki
Otsuru, Mitsunobu
Hasegawa, Takumi
Akashi, Masaya
Yamada, Shin-ichi
Kurita, Hiroshi
Okura, Masaya
Yamakawa, Nobuhiro
Kirita, Tadaaki
Yanamoto, Souichi
Umeda, Masahiro
Kojima, Yuka
author_facet Sakamoto, Yuki
Otsuru, Mitsunobu
Hasegawa, Takumi
Akashi, Masaya
Yamada, Shin-ichi
Kurita, Hiroshi
Okura, Masaya
Yamakawa, Nobuhiro
Kirita, Tadaaki
Yanamoto, Souichi
Umeda, Masahiro
Kojima, Yuka
author_sort Sakamoto, Yuki
collection PubMed
description The prognosis of oral cancer that has metastasized to the contralateral cervical lymph nodes is poor, although the appropriate treatment method has not been established because of its rarity. A multicenter retrospective study on the treatment and prognosis of pN2c oral cancer patients was conducted. We investigated the treatment and prognosis of 62 pN2c patients out of 388 pN+ patients with oral squamous cell carcinomas. Statistical analysis was performed on the various factors with overall survival (OS) and disease specific survival (DSS). In multivariate cox regression analysis, advanced T stage was significantly correlated with poor OS (p = 0.011) and DSS (p = 0.023) of patients with pN2c neck. In pN2c patients, OS, DSS, and neck control was not different between those undergoing ipsilateral neck dissection initially and those undergoing bilateral neck dissection. Thus, contralateral elective neck dissection is not recommended. The most important risk factor for prognosis in pN2c oral cancer patients is advanced T stage. No evidence was found to recommend contralateral elective neck dissection in clinically N1/2b patients. Therefore, the indication for contralateral elective neck dissection in N1/2b patients should be carefully determined in consideration of individual conditions.
format Online
Article
Text
id pubmed-9368347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93683472022-08-12 Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis Sakamoto, Yuki Otsuru, Mitsunobu Hasegawa, Takumi Akashi, Masaya Yamada, Shin-ichi Kurita, Hiroshi Okura, Masaya Yamakawa, Nobuhiro Kirita, Tadaaki Yanamoto, Souichi Umeda, Masahiro Kojima, Yuka Int J Environ Res Public Health Article The prognosis of oral cancer that has metastasized to the contralateral cervical lymph nodes is poor, although the appropriate treatment method has not been established because of its rarity. A multicenter retrospective study on the treatment and prognosis of pN2c oral cancer patients was conducted. We investigated the treatment and prognosis of 62 pN2c patients out of 388 pN+ patients with oral squamous cell carcinomas. Statistical analysis was performed on the various factors with overall survival (OS) and disease specific survival (DSS). In multivariate cox regression analysis, advanced T stage was significantly correlated with poor OS (p = 0.011) and DSS (p = 0.023) of patients with pN2c neck. In pN2c patients, OS, DSS, and neck control was not different between those undergoing ipsilateral neck dissection initially and those undergoing bilateral neck dissection. Thus, contralateral elective neck dissection is not recommended. The most important risk factor for prognosis in pN2c oral cancer patients is advanced T stage. No evidence was found to recommend contralateral elective neck dissection in clinically N1/2b patients. Therefore, the indication for contralateral elective neck dissection in N1/2b patients should be carefully determined in consideration of individual conditions. MDPI 2022-07-28 /pmc/articles/PMC9368347/ /pubmed/35954583 http://dx.doi.org/10.3390/ijerph19159229 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sakamoto, Yuki
Otsuru, Mitsunobu
Hasegawa, Takumi
Akashi, Masaya
Yamada, Shin-ichi
Kurita, Hiroshi
Okura, Masaya
Yamakawa, Nobuhiro
Kirita, Tadaaki
Yanamoto, Souichi
Umeda, Masahiro
Kojima, Yuka
Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
title Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
title_full Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
title_fullStr Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
title_full_unstemmed Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
title_short Treatment and Prognosis of Oral Cancer Patients with Confirmed Contralateral Neck Metastasis: A Multicenter Retrospective Analysis
title_sort treatment and prognosis of oral cancer patients with confirmed contralateral neck metastasis: a multicenter retrospective analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368347/
https://www.ncbi.nlm.nih.gov/pubmed/35954583
http://dx.doi.org/10.3390/ijerph19159229
work_keys_str_mv AT sakamotoyuki treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT otsurumitsunobu treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT hasegawatakumi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT akashimasaya treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT yamadashinichi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT kuritahiroshi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT okuramasaya treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT yamakawanobuhiro treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT kiritatadaaki treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT yanamotosouichi treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT umedamasahiro treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis
AT kojimayuka treatmentandprognosisoforalcancerpatientswithconfirmedcontralateralneckmetastasisamulticenterretrospectiveanalysis